- Editorial
520 Views
1 Page
In This Issue of Current Oncology
- M. Chasen
Promoting best gynecologic oncology practice is the subject of a manuscript from the Society of Gynecologic Oncologists of Canada. [...]
- 3.4Impact Factor
- 4.9CiteScore
- 22 daysTime to First Decision
- Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Current Oncology, Volume 13, Issue 3
June 2006 - 5 articles
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles (5)
- Article
758 Views
5 Pages
Promoting Best Gynecologic Oncology Practice: A Role For The Society of Gynecologic Oncologists of Canada
- L. M. Elit,
- M. Johnston,
- M. Brouwers,
- M. Fung- Kee-Fung,
- G. Browman and
- I. D. Graham
During March 30–April 1, 2005, the Society of Gynecologic Oncologists of Canada (GOC) and the Canadian Strategy for Cancer Control (CSCC) Clinical Practice Guidelines Action Group (CPG-AG) met to • determine how GOC would like to influence practice i...
- Article
26 Citations
1,015 Views
8 Pages
Impact of Geometric Uncertainties on Dose Distribution During Intensity Modulated Radiotherapy of Head-and-neck Cancer: The Need for a Planning Target Volume and A Planning Organ-at-Risk Volume
- O. Ballivy,
- W. Parker,
- T. Vuong,
- G. Shenouda and
- H. Patrocinio
We assessed the effect of geometric uncertainties on target coverage and on dose to the organs at risk (OARS) during intensity-modulated radiotherapy (IMRT) for head-and-neck cancer, and we estimated the required margins for the planning target volum...
- Review
23 Citations
901 Views
13 Pages
Maximal Androgen Blockade for the Treatment of Metastatic Prostate Cancer—A Systematic Review
- H. Lukka,
- T. Waldron,
- L. Klotz,
- E. Winquist,
- J. Trachtenberg and
- on behalf of the Genitourinary Cancer Disease Site Group of the Cancer Care Ontario Program in Evidence-Based Care
Introduction: Maximal androgen blockade (mab) versus castration alone in patients with metastatic prostate cancer has been extensively evaluated in randomized trials. The inconsistent results have led to the publication of multiple meta-analyses. The...
- Review
44 Citations
1,237 Views
9 Pages
Natural Health Products That Inhibit Angiogenesis: A Potential Source for Investigational New Agents to Treat Cancer—Part 2
- S.M. Sagar,
- D. Yance and
- R.K. Wong
The herbalist has access to hundreds of years of observational data on the anticancer activity of many herbs. Laboratory studies are expanding the clinical knowledge that is already documented in traditional texts. The herbs that are traditionally us...
Get Alerted
Add your email address to receive forthcoming issues of this journal.
Curr. Oncol. - ISSN 1718-7729